Rep. Tim Moore Buys Centene Corporation (NYSE:CNC) Stock

Representative Tim Moore (R-North Carolina) recently bought shares of Centene Corporation (NYSE:CNC). In a filing disclosed on August 05th, the Representative disclosed that they had bought between $15,001 and $50,000 in Centene stock on July 18th.

Representative Tim Moore also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Krispy Kreme (NASDAQ:DNUT) on 7/30/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/30/2025.
• Purchased $15,001 – $50,000 in shares of Harley-Davidson (NYSE:HOG) on 7/30/2025.
• Purchased $15,001 – $50,000 in shares of Verizon Communications (NYSE:VZ) on 7/29/2025.
• Purchased $15,001 – $50,000 in shares of Intel (NASDAQ:INTC) on 7/29/2025.
• Purchased $1,001 – $15,000 in shares of Krispy Kreme (NASDAQ:DNUT) on 7/29/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/29/2025.
• Purchased $1,001 – $15,000 in shares of Centene (NYSE:CNC) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 7/21/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/21/2025.

Centene Stock Down 2.7%

Shares of CNC opened at $25.20 on Thursday. The company’s 50-day moving average price is $42.15 and its 200 day moving average price is $54.03. Centene Corporation has a 12-month low of $25.11 and a 12-month high of $80.59. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. The firm has a market cap of $12.37 billion, a P/E ratio of 6.24, a price-to-earnings-growth ratio of 1.06 and a beta of 0.40.

Centene (NYSE:CNC) last released its quarterly earnings results on Friday, July 25th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.39). The company had revenue of $48.74 billion during the quarter, compared to analysts’ expectations of $44.71 billion. Centene had a net margin of 1.15% and a return on equity of 9.57%. Centene’s revenue was up 22.4% on a year-over-year basis. During the same period last year, the firm posted $2.42 earnings per share. On average, sell-side analysts forecast that Centene Corporation will post 6.86 earnings per share for the current year.

Insider Buying and Selling

In other Centene news, Director Theodore R. Samuels II bought 9,000 shares of the firm’s stock in a transaction dated Monday, July 28th. The stock was acquired at an average price of $27.62 per share, for a total transaction of $248,580.00. Following the completion of the purchase, the director owned 32,000 shares of the company’s stock, valued at approximately $883,840. This represents a 39.13% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.36% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on CNC. Cantor Fitzgerald cut Centene from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $65.00 to $38.00 in a research note on Monday, July 28th. TD Cowen reissued a “hold” rating and set a $33.00 target price (down previously from $73.00) on shares of Centene in a research note on Monday, July 21st. Barclays dropped their target price on Centene from $65.00 to $45.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 2nd. Wells Fargo & Company cut shares of Centene from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $72.00 to $30.00 in a research report on Wednesday, July 23rd. Finally, Oppenheimer dropped their price objective on shares of Centene from $51.00 to $43.00 and set an “outperform” rating for the company in a report on Monday, July 28th. One equities research analyst has rated the stock with a sell rating, fourteen have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $42.20.

Institutional Trading of Centene

A number of large investors have recently made changes to their positions in the company. Invesco Ltd. increased its position in Centene by 5.1% during the first quarter. Invesco Ltd. now owns 11,091,964 shares of the company’s stock worth $673,393,000 after buying an additional 536,508 shares during the period. AQR Capital Management LLC increased its holdings in shares of Centene by 42.7% in the 1st quarter. AQR Capital Management LLC now owns 11,049,494 shares of the company’s stock valued at $669,820,000 after acquiring an additional 3,306,796 shares during the period. Ameriprise Financial Inc. raised its position in Centene by 32.3% in the 4th quarter. Ameriprise Financial Inc. now owns 6,469,062 shares of the company’s stock valued at $391,854,000 after purchasing an additional 1,578,917 shares during the last quarter. Northern Trust Corp boosted its stake in Centene by 9.1% during the 4th quarter. Northern Trust Corp now owns 5,294,816 shares of the company’s stock worth $320,760,000 after purchasing an additional 443,121 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Centene by 3.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,810,489 shares of the company’s stock worth $292,045,000 after purchasing an additional 143,573 shares during the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina’s 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Moore (Republican Party) ran for election to the U.S. House to represent North Carolina’s 14th Congressional District. He won in the general election on November 5, 2024.

Moore served as speaker of the House from 2015 to 2025.

Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.